Home > Insider Trading > Filing (0000950170-25-032638)

Filing Details

Accession Number:: 0000950170-25-032638
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-03-04 18:41:11
Reporting Period:: 2025-02-28

Filing Date:: 2025-03-04
Accepted Time:: 2025-03-04 18:41:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1294133	Inogen Inc	INGN	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1802639	Merrill Raymond Kevin Smith	C/O Inogen, Inc. 859 Ward Drive Goleta CA 93111	Ceo And President	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2025-03-01	1,500	$8.33	16,054	No	4	A	Direct
Common Stock	Acquisiton	2025-03-01	28,333	$0.00	44,387	No	4	M	Direct
Common Stock	Disposition	2025-03-01	13,700	$8.33	30,687	No	4	F	Direct
Common Stock	Acquisiton	2025-03-01	53,975	$0.00	84,662	No	4	A	Direct
Common Stock	Disposition	2025-03-01	26,097	$8.33	58,565	No	4	F	Direct
Common Stock	Acquisiton	2025-03-03	11,709	$8.56	70,274	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	M	Direct
No	4	F	Direct
No	4	A	Direct
No	4	F	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Acquisiton	2025-02-28	90,036	$0.00	90,036	$0.00
Common Stock	Restricted Stock Unit	Disposition	2025-03-01	28,333	$0.00	28,333	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
90,036			No	4	A	Direct
56,667			No	4	M	Direct

Footnotes

Shares acquired through the Company's 2014 Employee Stock Purchase Plan.
The reported shares were withheld to cover the reporting person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2025.
The reported securities represent shares earned and vested on March 1, 2025 based on achievement of the financial performance conditions for the 2024 fiscal year that were approved as part of the 2023 performance-based restricted stock unit award granted on November 10, 2023.
The reported shares were withheld to cover the reporting person's tax withholding liability in connection with the 2023 performance-based restricted stock unit award granted on November 10, 2023 and vested on March 1, 2025.
Represents the weighted average share price of an aggregate total of 11,709 shares sold in the price range of $8.455 to $8.6298 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2026 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.
1/3rd of the restricted stock units vested on March 1, 2025 (the "2025 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2025 Vesting Commencement Date.